Best of European Society for Medical Oncology Congress | Conference

Brian Rini, MD, on Key Practice Changing Abstracts in Prostate Cancer From 2021 ESMO
October 30, 2021

Brian Rini, MD, discussed abstracts presented during the 2021 ESMO Congress that will have an immediate impact on prostate cancer.

Scott T. Tagawa, MD, MS, on Compelling ESMO Data for Metastatic Castration-Sensitive Prostate Cancer
October 18, 2021

Scott Tagawa, MD, MS, detailed 2 presentations from ESMO’s presidential symposium that he thinks will have an impact on treating patients with metastatic castration-sensitive prostate cancer.

Alicia Morgans, MD, MPH Discusses the Importance of Patient Support Networks During the COVID-19 Pandemic
October 08, 2021

CancerNetwork® sat down with Alicia Morgans MD, MPH, at the 2021 European Society for Medical Oncology to talk about the important role that patient support networks play for those with cancer and the challenge of separating patients from their loved ones during the COVID-19 pandemic.

Andrew Armstrong, MD, MSc, Discusses Survival Data in mHSPC From ARCHES Trial at 2021 ESMO
October 07, 2021

Andrew Armstrong, MD, MSc, spoke about key findings, patient crossover, and takeaways from the ARCHES trial for metastatic hormone-sensitive prostate cancer.

Ravi A. Madan, MD, Discusses the Significance of the PEACE-1 Trial With Docetaxel, Abiraterone, ADT, and Radiotherapy in mCSPC
October 06, 2021

Ravi A. Madan, MD, discusses the potential impact of docetaxel, abiraterone acetate, androgen deprivation therapy, and radiotherapy on patients with metastatic castration-sensitive prostate cancer.

Solange Peters, MD, PhD, Highlights Practicing Changing Research From the 2021 ESMO Annual Congress
September 29, 2021

Solange Peters, MD, PhD, detailed several important abstracts from the Presidential Symposia at the 2021 ESMO Congress she believes will be practice changing.

Marshall Posner, MD, on the Promise of Personalized mRNA Vaccines in Solid Malignancies
September 28, 2021

Marshall Posner, MD, detailed the potential for personalized mRNA vaccines to treat patients with various different tumors and what information is still needed.

Solange Peters, MD, PhD, Discusses Key Abstracts Presented at the 2021 ESMO Congress
September 27, 2021

ESMO’s president, Solange Peters, MD, PhD, discussed a handful of key abstracts presented during the 3 Presidential Symposia sessions at the 2021 ESMO Congress.

David O’Malley, MD, Discusses Findings From the OReO Trial in Ovarian Cancer at 2021 ESMO
September 23, 2021

CancerNetwork® sat down with David O’Malley, MD, at the 2021 European Society for Medical Oncology to talk about the OReO trial and how these findings impact what’s already known about PARP inhibitors for the treatment of ovarian cancer.

Jason Luke, MD, Discusses Advancement of Immunotherapy For Metastatic Disease at 2021 ESMO
September 22, 2021

CancerNetwork® sat down with Jason Luke, MD, at the 2021 European Society for Medical Oncology Congress to talk about the latest developments in the use of immunotherapy for metastatic disease.